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Background: Routine placement of intraperitoneal drains has been shown to be ineffective or potentially harmful
in various abdominal surgical procedures. Studies assessing risks and benefits of abdominal drains for pancreatic
resections have demonstrated inconsistent results. We thus performed a systematic review of the literature and
meta-analyzed outcomes of pancreatic resections with and without intraoperative placement of drains.
Methods: A database search according to the PRISMA guidelines was performed for studies on pancreatic
resection with and without intraperitoneal drainage. The subgroup ‘pancreaticoduodenectomy’ was analyzed
separately. The quality of studies was assessed using the MINORS and STROBE criteria. Pooled estimates of
morbidity, mortality and length of hospital stay were calculated using random effects models.
Results: Only two randomized trials were identified. Their results were contradictory. We thus included six further,
retrospective studies in the meta-analysis. However, with I2 = 68% for any kind of complication, the estimate of
inter-study heterogeneity was high. While overall morbidity after any kind of pancreatic resection was lower without
drains (p = 0.04), there was no significant difference in mortality rates. In contrast, pooled estimates of
outcomes after pancreaticoduodenectomy demonstrated no differences in morbidity (p = 0.40) but increased
rates of intraabdominal abscesses (p = 0.04) and mortality (p = 0.04) without intraperitoneal drainage.
Conclusion: Although drains are associated with slightly increased morbidity for pancreatic resections, routine
omission of drains cannot be advocated, especially after pancreaticoduodenectomy. While selective drainage
seems reasonable, further efforts to generate more reliable data are questionable because of the current
studies and the presumed small differences in outcomes.
Trial registration: Systematic review registration number CRD42014007497.
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Intraperitoneal drains are frequently placed at the end of
complex abdominal operations [1]. These drains were
initially thought to enable the early identification of
hemorrhage or anastomotic dehiscence, allowing timely
re-operations. It has also been hypothesized that prophy-
lactic intraperitoneal drainage can prevent additional* Correspondence: kleeff@tum.de
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However, many studies, including randomized controlled
trials, systematic reviews and meta-analyses have shown
that routine drainage after various general surgical proce-
dures such as appendectomy, cholecystectomy, hepatec-
tomy, colectomy and gastrectomy does not reduce the
number of complications [1]. Some of these studies even
found an increased risk of complications with drains [2,3].
This is thought to be a result of an artificial access to
the peritoneal cavity, of an inflammatory response to
the drain as a foreign body, and of increased painLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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voring the omission of drains, clinical practice has only
slowly changed [1].
The evidence for or against intraperitoneal drainage
after pancreatic resection is much less clear. Here, drains
are placed to detect hemorrhage in the immediate post-
operative period, but are also frequently left in place for
an extended period of time to allow for detection of
leakage of the pancreatic anastomosis/pancreatic stump
[2]. Though this concept has not been substantiated by
reliable evidence, it is the standard of care all over the
world. Interestingly, it had already been challenged in
1992, when Jeekel and co-authors published a series of
22 patients without intraperitoneal drainage [4]. Here,
omission of drains was not associated with an increased
rate of complications. In 1998, the first retrospective
study from the Memorial Sloan Kettering Cancer Center
(MSKCC) was published, comparing patients with intra-
peritoneal drainage to those without. There was “no statis-
tical difference in the rate of fistula, abscess, CT drainage,
or length of hospital stay” [5]. Because of these findings,
the MSKCC group at that time designed and conducted a
randomized controlled trial to generate better evidence.
The results were published in the Annals of Surgery in
2001 [6]. 179 patients with pancreaticoduodenectomy or
distal pancreatectomy had been randomized to the drain
or no drain group. There was no significant difference in
the number or type of complications between the groups.
Thus, for the first time, level 1b evidence had shown that
intraperitoneal drains may not be necessary after pancre-
atic resection. Several years later, the authors of this ran-
domized study validated their promising initial results
by another retrospective report on 1,122 patients of
their institution. They again advocated the benefits of
omitting drains [7]. However, the latter retrospective non-
randomized analysis also revealed that the participating
surgeons still decided to place a drain in roughly half of
all pancreatic resections.
Subsequently, with only very few exceptions, several
retrospective reports did not identify significant differ-
ences between drain and no drain groups regarding mor-
bidity, pancreatic fistula, abscess, interventional radiology
procedures, re-operation, length of hospital stay, or mor-
tality [5,7-11]. These studies demonstrated that drains
could probably be safely omitted after pancreatic resec-
tions. However, the available level of evidence was still not
convincingly enough to change clinical practice. A main
reason for this was that the prospective, randomized trial
from the Memorial Sloan Kettering Cancer Center [6] had
not reported complications (and particularly, leak rates)
according to current standards – owing to the lack of such
reporting standards at that time. This reasoning prompted
the initiation of a multi-center, randomized trial whose
results have recently been reported [12]. In this study,137 patients with pancreaticoduodenectomy for benign
or malignant pancreatic pathologies were randomized to
placement or no placement of an intraperitoneal drain.
The study was conducted at nine academic high-volume pan-
creas surgery centers in the United States. Randomization by
demographics and clinical characteristics was performed
thoroughly, minimizing the risk for any systematic bias.
Unexpectedly, the group of patients without a drain had a
higher complication rate, a higher complication severity,
and most importantly, a higher mortality rate (12% versus
3%). The trial was thus prematurely terminated by the
Institutional Review Board. These results were surprising
[12,13], given that the trial has been multi-centric and
all institutions had a vast experience in pancreatic sur-
gery. In addition, a recent retrospective study published by
one of the authors of the trial had demonstrated less com-
plications and comparable mortality with omission of
drains after pancreaticoduodenectomy and distal pancrea-
tectomy [8].
Because of these recent publications, we sought to
provide pooled estimates of the available literature to
allow for a better interpretation of the current evidence.
Methods
Literature search
This meta-analysis was performed according to the
PRISMA (Preferred Reporting Items for Systematic Re-
views and Meta-Analyses) statement [14]. The literature
screening was conducted by two independent re-
searchers (U.N. and T.C.M.) in January 2014, without
time or language restriction for all articles mentioning the
phrases “pancreas” together with “resection” and “drain”.
No other limits were applied. Reviewed databases were
Pubmed/Medline, Science direct, The Cochrane Central
register of controlled trials/Cochrane Library, and EMBASE.
Congress abstracts and personal communications were
not considered in order to warrant a reproducible meta-
analysis of sufficient quality. Articles were included when
they reported clinical studies on human subjects with any
kind of benign or malignant elective pancreatic resections.
The studies needed to compare a group of patients with
any kind of pancreatic resection and postoperative intra-
peritoneal drainage (control group) versus a group of
patients with comparable pancreatic resections but no
postoperative intraperitoneal drainage (intervention group).
Studies reporting on enucleation or drainage for pan-
creatitis without resection were excluded. We included
studies regardless of their design (prospective/retrospective,
randomized controlled/non randomized controlled, cohort/
case–control) and length of follow up. Identified stud-
ies were evaluated by title, abstract, or full reading
until inclusion or exclusion criteria were met, respect-
ively. In addition, references of included studies were
screened.
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Eligible studies were evaluated regarding study design,
patient population, underlying pancreatic diseases, surgi-
cal procedures, and time of recruitment, as reported in
Table 1. The primary outcome was overall morbidity
after pancreatic resection with or without an intraperito-
neal drain. A subgroup analysis was performed for pan-
creaticoduodenectomy. Secondary outcomes that were
not reported in all studies were rates of minor and major
complications (according to the Clavien/Dindo classifi-
cation system [15] grade I-II and III-V, respective), pan-
creatic fistulas (according to the ISGPF classification
system [16] grade B-C), intraabdominal abscesses, the
need for interventional radiology procedures (insertion
of drainage catheters), the need for re-operations, the
length of hospital stay, and mortality (Table 2). To assess
study quality and reporting bias, the MINORS [17] and
STROBE [18] criteria were applied. Each study was eval-
uated for the 12 MINORS items with 0, 1, or 2 points,
and for all 34 STROBE items with 0 or 1 point, respect-
ively. The results of the MINORS as well as STROBE
questions were added and reported in percentages to
allow for a review of the individual study quality (Table 1).
Zero percent depicts the worst possible study design and
100% depicts a perfectly conducted study. This meta-
analysis was registered at the PROSPERO international
prospective register of systematic reviews with the num-
ber CRD42014007497, as reported on www.crd.york.ac.
uk/PROSPERO. Because all original data of this study has
already been published in individual reports and no kind
of research has been performed on living individuals,
no ethics approval was requested at the institutional
review board.
Statistical analysis
The dichotomous data on morbidity and mortality were
analyzed in random effects meta-analyses by the Mantel-Table 1 Characteristics, patient numbers, and quality of the e
Year Author Study
design
Patients Inclusion year
(from - until)
Ag
(yea
1998 Heslin [5] Retrospective 89 1994 - 1996 65 (m
2001 Conlon [6] Prospective
randomized
179 n.s. - n.s. 65 (m
2011 Fisher [8] Time cohort 226 2004 - 2010 62 (me
2012 Paulus [10] Retrospective 69 1997 - 2011 55 (me
2013 Adham [9] Retrospective 242 2005 - 2012 62 (me
2013 Mehta [11] Retrospective 709 2005 - 2012 62 (m
2013 Correa-Gallego [7] Retrospective 1122 2006 - 2011 65 (m
2014 Van Buren [12] Prospective
randomized
137 2011 - 2012 63 (m
If not indicated otherwise, numbers of patients are stated. For the explanation of st
specified, PD, pancreaticoduodenectomy.Haenszel method, using odds ratios (OR) and 95% confi-
dence intervals (CI) as the effect measures. To estimate
a pooled mean difference regarding the length of hos-
pital stay using a random effects meta-analysis required
the mean and standard deviation of length of stay for
each group in each study. If the studies reported on me-
dian and interquartile range (Fisher et al. [8], Van Buren
et al. [12]) or median and range (Paulus et al. [10],
Adham et al. [9]), but not mean and standard deviation,
it was estimated as suggested by the Cochrane Hand-
book for Systematic Reviews of Interventions [19]. Due
to the applied approximations, the results regarding
length of hospital stay should be interpreted with cau-
tion. Inter-study heterogeneity for the respective ana-
lyses is shown in the figures as I2. Data are displayed in
total numbers and are illustrated by Forest plots with p-
values and 95% confidence intervals. Publication bias
was assessed by a funnel plot. All statistical tests were
performed two-sided, and p-values less than 0.05 were
considered to be statistically significant. No correction
of p-values was applied to adjust for multiple compari-
sons. However, results of all statistical tests conducted
were thoroughly reported, so that an informal adjust-
ment of p-values can be performed while reviewing the data
[20]. No additional analyses other than the reported ones
were performed. All analyses were performed using the
software Revman 5.2.7 for Windows, available online for
free at http://ims.cochrane.org/revman/download (down-
loaded January 04, 2014).
Results
Identified studies
Based on the search criteria, 4,682 articles were screened
and assessed for eligibility. Of those, duplicates were omit-
ted and 82 abstracts were reviewed in more detail. All ab-
stracts were available either in English or were translated
into English. Twenty one studies (all in English) requiredight studies that were included in this meta-analysis
e
rs)
Gender
(men,
women)
Disease
(malignant,
benign)
Type of
resection
(PD, distal, others)
Study quality
MINORS STROBE
ean) 50, 39 78, 11 89, 0, 0 83% 58%
ean) 89, 90 176, 3 139, 40, 0 79% 77%
dian) 97, 129 113, 113 153, 73, 0 60% 69%
dian) n.s., n.s. 52, 17 0, 69, 0 65% 55%
dian) 127, 115 180, 62 148, 66, 28 58% 66%
ean) 352, 357 451, 258 709, 0, 0 70% 69%
ean) 548, 574 786, 336 739, 350, 33 50% 60%
ean) 75, 62 95, 42 137, 0, 0 88% 90%
udy quality according to MINORS and STROBE criteria, see in the text. n.s., not
Table 2 Numbers of included patients, complication rates, intervention rates, length of hospital stay, and mortality for the drain and no drain group
Year Author All patients Any
complication
Minor
complication
Major
complication
Fistula
(grade B/C)
Abscess Rad.
Intervention
Re-
operation
Length of hospital stay
(d, estimated mean ± SD)
Mortality
Drain No
drain
Drain No
drain
Drain No
drain
Drain No
drain
Drain No
drain
Drain No
drain
Drain No
drain
Drain No
drain
Drain No
drain
Drain No
drain
1998 Heslin [5] 51 38 23 15 13 9 14 8 3 1 3 0 2 1 1 3 12 ± 7 12 ± 6 n.s. n.s.
2001 Conlon [6] 88 91 66 57 93* 83* 43** 39** 11 0 6 6 11 7 8 4 n.s. n.s. 2 2
2011 Fisher [8] 179 47 117 22 171*** 23*** 38 7 21 5 10 2 4 5 8 0 7 ± 2 7 ± 1 1 1
2012 Paulus [10] 39 30 15 20 n.s. n.s. n.s. n.s. 6 0 8 7 5 7 11 8 9 ± 2.5 6.5 ± 1 1 0
2013 Adham [9] 130 112 83 45 46 27 32 48 12 13 16 15 8 14 16 17 16.2 ± 24 17.8 ± 31 7 5
2013 Mehta [11] 251 458 171 248 n.s. n.s. 62 75 41 35 n.s. n.s. 21 29 14 26 n.s. n.s. 5 11
2013 Correa-Gallego [7] 553 569 301 272 n.s. n.s. 185 150 149 102 n.s. n.s. 103**** 83***** 3**** 2***** n.s. n.s. 6**** 12*****
2014 Van Buren [12] 68 69 50 55 n.s. n.s. 21 28 8 14 8 18 6 16 2 6 7 ± 2 8 ± 5 2 8
These values were used for the meta-analysis. Consider the difficulty of comparing the length of hospital stay due to its varying specifications, as mentioned in the text. d, days, SD, standard deviation, n.s.,
not specified.
*Out of 176 (multiple mentions).
**Out of 82 (multiple mentions).
***Out of 194 (multiple mentions).
****Out of 540 (subgroup).
*****Out of 549 (subgroup).
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studies were excluded because the abstracts revealed that
the inclusion criteria were not met. Subsequently, the ref-
erence lists of all reviewed articles were checked manually,
which did not lead to the identification of additional stud-
ies. Figure 1 displays the flow diagram of the screening
and inclusion process according to the PRISMA statement
[14]. Eight studies met the full inclusion criteria and were
included in the meta-analysis. Table 1 gives an overview of
the included studies, patient numbers, time spans of
recruitment, clinical data, and estimation of the methodo-
logical study quality according to MINORS [17] and
STROBE [18] criteria. The methodological quality of all
studies was at least 50% (of a maximal possible 100%), andFigure 1 Flow chart with the number of screened, assessed, and finalassessment regarding MINORS versus STROBE criteria
did not show any relevant discrepancies for the individual
studies (mean value MINORS: 69%, mean value STROBE:
68%; p = 0.80, paired t test). The smallest study [10] re-
ported on 69 patients, while the largest study [7] reported
on 1,122 patients. The two prospective randomized stud-
ies were from the years 2001 [6] (n = 179 patients) and
2014 [12] (n = 137 patients). The latter was the only
multi-center study [12]; all other studies were single cen-
ter reports. In total, 1,414 patients without drain were
compared to 1,359 patients with drain. Three of all eight
studies reported only on pancreaticoduodenectomy and
were thus eligible for subgroup analysis [5,11,12]. Add-
itionally, Correa-Gallego et al. [7] reported separately only included studies in the meta-analysis.
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included in the subgroup analysis, comparing 565 patients
without drain to 370 patients with drain.
Drain versus no drain: any complication
Table 2 shows the numbers of patients for the parame-
ters that were analyzed. All eight studies and all 2,773
patients were included for the comparison of any com-
plication. A funnel plot for potential publication bias re-
garding the development of any complication after
pancreatic resection with and without drain is shown in
Figure 2 and does not provide evidence of publication
bias. All studies except for two (including one random-
ized controlled trial) [10,12] revealed a lower morbidity
in the no drain group. Overall heterogeneity was high
with I2 = 68%. Patients without drain had significantly
less complications (p = 0.04, OR 0.70, 95% CI 0.51 –
0.98, Figure 3). If only the two prospective randomized
studies [6,12] were taken into account, this effect was
not significant (p = 0.75, OR 0.86, 95% CI 0.35 – 2.14,
graph not shown).
Drain versus no drain: specific complications
Not all studies reported on the number of patients with
minor complications (grade I and II [15]), major complica-
tions (grade III – V [15]), pancreatic fistulas (grade B and C
[16]), intraabdominal abscesses, the need for interven-
tional radiology procedures, and the need for re-operations.Any complic
0.01 0.1
0
0.4
0.2
0.6
0.8
1.0
SE (logOR)
Figure 2 Funnel plot for the primary outcome “any complication”. De
asymmetry was detected that would suggest selection bias. OR, odds ratioPooled estimates showed no differences in rates of minor
and major complications (p = 0.19 and p = 0.67, respect-
ively), pancreatic fistula, intraabdominal abscess, the
numbers of interventional radiology procedures, and re-
operations (Figures 3, 4 and 5).
Drain versus no drain: length of hospital stay and
mortality
The length of hospital stay was reported in all eight
studies. However, the days of the hospital stay were re-
ported as mean, median, or without any specification,
making a robust comparison difficult. Using the estima-
tions as described in the Methods section, there was no
significant difference in the length of hospital stay. Post-
operative mortality was reported in seven studies, with
an observation period of up to three months. Pooled es-
timates of mortality rates did not show a significant dif-
ference (Figure 5).
Subgroup analysis: pancreaticoduodenectomy
Outcomes after pancreaticoduodenectomy were ana-
lyzed separately. Here, no differences were found for any
complication (p = 0.40; Figure 6), minor complications
(p = 0.85), major complications (p = 0.61), pancreatic fis-
tula (p = 0.63), the need for interventional radiology pro-
cedures (p = 0.99), re-operation rates (p = 0.39), or the
length of hospital stay (p = 0.16; data not shown). How-
ever, without drains the number of intraabdominalation
1 10 100
OR
spite the relatively low number of included studies (n = 8), no clear
, SE(logOR), standard error of the log OR.
Figure 3 Forrest plots for risk of any complication, minor and major complications for patients after all kinds of pancreatic resection,
with and without intraperitoneal drain. The overall effect is shown by the diamond, with level of significance (p-value), 95% confidence
intervals (CIs), and diversity between studies (Heterogeneity, I2).
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Figure 4 Forrest plots for risk of fistula, abscess, and interventional radiology procedures for patients after all kinds of pancreatic
resection, with and without intraperitoneal drain. The overall effect is shown by the diamond, with level of significance (p-value), 95%
confidence intervals (CIs), and diversity between studies (Heterogeneity, I2).
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Figure 5 Forrest plots for risk of re-operation and mortality, and difference in the length of hospital stay for patients after all kinds of
pancreatic resection, with and without intraperitoneal drain. The overall effect is shown by the diamond, with level of significance (p-value),
95% confidence intervals (CIs), and diversity between studies (Heterogeneity, I2).
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Figure 6 Forrest plots for risk of any complication, abscess, and mortality for patients after pancreaticoduodenectomy, with and
without intraperitoneal drain. The overall effect is shown by the diamond, with level of significance (p-value), 95% confidence intervals (CIs),
and diversity between studies (Heterogeneity, I2).
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http://www.biomedcentral.com/1471-2482/14/76abscesses was significantly increased (p = 0.04, OR 2.27,
95% CI 1.02 – 5.05; Figure 6) and mortality was consid-
erably higher (p = 0.04, OR 2.47, 95% CI 1.03 – 5.94;
Figure 6).
Discussion
In this meta-analysis, prophylactic intraperitoneal drain-
age after pancreatic resection increased the risk of compli-
cations, but not the rate of mortality. Pooled estimates of
outcomes in the subgroup ‘pancreaticoduodenectomy’
demonstrated different results. Here, the rate of complica-
tions was comparable with or without a drain; however,
mortality was increased by omission of intraperitoneal
drains.
It could be argued that drains following pancreatic re-
section (as in other abdominal operations) are associated
with an, albeit small 1.4-fold (OR 1.43, 95% CI 1.02 –
1.96), increased risk of morbidity without significantly
influencing mortality. In the case of pancreaticoduode-
nectomy, leakage/dehiscence of the pancreatic-intestinal
anastomosis is a potentially dreadful complication sig-
nificantly contributing to the overall mortality following
this procedure. From the clinical experience as well as
from the data of the included studies, it is possible to
conceive that a drain could help to detect a leak earlier
and to drain this potentially hazardous fluid (leading to
haemorrhage etc.) earlier and more efficiently than an
interventional placed drain. Thus, omission of a routine
drain following pancreaticoduodenectomy results in a
2.5-fold (OR 2.47, 95% CI 1.03 – 5.94) increased risk of
mortality.
These conclusions are supported by the eight included
studies, making this meta-analysis the most comprehen-
sive so far. Despite the proper methodological quality of
all includes trials, this study has limitations. Because of
the different surgical approaches, we performed a sub-
group analysis for pancreaticoduodenectomy. In general,
there are few studies available investigating the use of
drains for pancreatic resections, and only two prospect-
ive randomized trials exist. Especially in consideration of
the results of the most recent prospective multicenter
trial [12], future randomized studies may be ethically dif-
ficult to conduct.
The latter trial by Van Buren et al. [12] was stopped
preliminary due to the unexpectedly high rate of mortal-
ity after pancreaticoduodenectomy in the no drain
group. Unfortunately, the reasons for this outcome re-
main unclear, especially since it was highly contradictory
to prior studies. A thorough analysis of the potential fac-
tors contributing to these results is beyond the scope of
this review. However, it has to be acknowledged that this
was the first multicenter study with a well-planned study
protocol and the participation of only highly experienced
centers. Certainly, the results cannot be explained by themulticentric character, flaws in the study protocol or the
lack of experience in the participating centers. As such,
the data of the trial by Van Buren et al. have to be taken
as high quality evidence.
Recently, a meta-analysis by Rondelli et al. was pub-
lished, which also meta-analyzed the results of intraperi-
toneal drainage after pancreatic resection [21]. In
contrast to our meta-analysis, the results of the study by
Paulus et al. [10] were not included. Comparable to our
results, intraperitoneal drainage was identified to be as-
sociated with an increase in the total post-operative
complication rate (OR 1.52, 95% CI 1.30 – 1.78), and
mortality did not differ significantly between the drain/
no drain group. Rondelli et al. also performed a sub-
group analysis for pancreaticoduodenectomy. As for our
analysis, four studies were eligible and the authors found
no difference in mortality when analyzing the available
randomized study, or the remaining retrospective studies
separately. However, when analyzing all studies on pan-
creaticoduodenectomy together, there was still no signifi-
cant difference identified in the mentioned meta-analysis,
which is in contrast to our results.
Conclusion
Taking together the data for all pancreatic resections and
the subgroup analysis, intraperitoneal drains seem not to
be harmful, but may not be beneficial in general either.
This would argue for a concept of selective abdominal
drain application with placement of a prophylactic drain
according to patient factors (e.g. comorbidity, periopera-
tive risk, anticoagulation), pancreatic texture (e.g., small
pancreatic duct, soft tissue), surgeon (level of experience,
type of operation), and setting (e.g., missing 24/7 availabil-
ity of interventional radiology procedures) [13]. However,
mortality is increased if drains are omitted after pancreati-
coduodenectomy. Though this result is driven by the in-
clusion of the most recent randomized trial into this
meta-analysis, it should certainly be taken seriously. Thus,
it is very difficult to argue for an omission of drains after a
pancreaticoduodenectomy – even under circumstances
where anastomotic complications are unlikely. With a re-
duction of morbidity after any kind of pancreatic resection
however, omission of drains after distal pancreatectomy
may truly be an option. The results of a currently ongoing
randomized trial on distal pancreatectomy are eagerly
awaited.
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